SPOP-mediated RIPK3 destabilization desensitizes LPS/sMAC/zVAD-induced necroptotic cell death
Ga-Eun Lee1,2, Geul Bang3, Jiin Byun1
1BK21-4th, College of Pharmacy, The Catholic University of Korea, 43, Jibong-ro, Wonmi-gu, Bucheon- si, Gyeonggi-do, 14662, Republic of Korea.
Abstract:
RIPK1/RIPK3-MLKL signaling molecules are fundamental in initiating necroptotic cell death, but their roles in the development of colon cancer are unclear. This study reports that RIPK3 interacted with SPOP, a component of the E3 ligase within the Cul3 complex. This interaction leads to K48-linked ubiquitination and subsequent proteasomal degradation of RIPK3. Two distinct degron motifs, PETST and SPTST, were identified within the linker domain of RIPK3 for SPOP. RIPK3 phosphorylations at Thr403 by PIM2 and at Thr412/Ser413 by ERK2 are essential to facilitate its interaction with SPOP. Computational docking studies and immunoprecipitation analyses showed that these PIM2 and ERK2 phosphorylations bolster the stability of the RIPK3-SPOP interaction. In particular, mutations of RIPK3 at the degron motifs extended the half-life of RIPK3 by preventing its phosphorylation and subsequent ubiquitination. The deletion of SPOP, which led to increased stability of the RIPK3 protein, intensified LPS/sMAC/zVAD-induced necroptotic cell death in colon cancer cells. These findings underscore the critical role of the SPOP-mediated RIPK3 stability regulation pathway in controlling necroptotic cell death.
Insights
This study reveals how SPOP regulates RIPK3 stability via ubiquitination, impacting necroptotic cell death in colon cancer. Inhibiting this pathway enhances cancer cell death, offering new therapeutic targets.
Area of Science:
- Cellular Biology
- Molecular Oncology
- Biochemistry
Background:
- The roles of RIPK1/RIPK3-MLKL signaling in necroptosis are established, but their involvement in colon cancer development remains unclear.
- Understanding the regulatory mechanisms of these key necroptosis molecules is crucial for cancer research.
Purpose of the Study:
- To investigate the interaction between RIPK3 and SPOP and its implications for RIPK3 stability and necroptosis in colon cancer.
- To identify the specific molecular mechanisms governing RIPK3 degradation and its regulation by SPOP.
Main Methods:
- Co-immunoprecipitation assays to confirm RIPK3-SPOP interaction.
- Mass spectrometry and mutational analysis to identify ubiquitination sites and degron motifs.
- Western blotting to assess protein stability and phosphorylation levels.
- Cell viability assays to evaluate necroptotic cell death induction.
Main Results:
- RIPK3 interacts with SPOP, a component of the Cul3 E3 ligase complex, leading to K48-linked ubiquitination and proteasomal degradation of RIPK3.
- Two degron motifs (PETST and SPTST) in RIPK3's linker domain mediate SPOP interaction.
- Phosphorylation of RIPK3 at Thr403 (by PIM2) and Thr412/Ser413 (by ERK2) is essential for SPOP binding and subsequent degradation.
- Mutations at these degron sites stabilize RIPK3 by preventing phosphorylation and ubiquitination.
- SPOP deletion increases RIPK3 stability and potentiates necroptotic cell death in colon cancer cells.
Conclusions:
- SPOP-mediated regulation of RIPK3 stability through ubiquitination is a critical pathway controlling necroptosis in colon cancer.
- Targeting the SPOP-RIPK3 interaction or downstream signaling could represent a novel therapeutic strategy for colon cancer.
- This study elucidates a key mechanism linking necroptosis regulation to colon cancer progression.
Related Concept Videos
Necrosis
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
The Extrinsic Apoptotic Pathway
Phagocytosis of Apoptotic Cells
Normal cells contain receptors that prevent them from being recognized...
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
The Intrinsic Apoptotic Pathway


